首页|活血化瘀方穴位贴敷联合阿替普酶静脉溶栓治疗脑梗死临床观察

活血化瘀方穴位贴敷联合阿替普酶静脉溶栓治疗脑梗死临床观察

扫码查看
目的 探讨活血化瘀方穴位贴敷联合阿替普酶静脉溶栓治疗脑梗死的临床疗效.方法 选取医院 2019 年 1 月至 2023 年 1 月收治的脑梗死患者 102 例,按随机数字表法分为观察组和对照组,各 51 例.两组患者均予阿替普酶静脉溶栓治疗,观察组患者加用活血化瘀方穴位贴敷,均连续治疗 7d.结果 观察组总有效率为 92.16%,显著高于对照组的 72.55%(P<0.05).治疗后,两组患者的Barthel指数(BI)评分均显著升高(P<0.05),中医证候积分和美国国立卫生研究院卒中量表(NIHSS)评分均显著降低(P<0.05),且观察组均显著优于对照组(P<0.05);两组患者的超氧化物歧化酶(SOD)、谷胱甘肽过氧化物酶(GSH-Px)水平均显著升高(P<0.05),丙二醛(MDA)水平均显著降低(P<0.05),且观察组均显著优于对照组(P<0.05).治疗期间,观察组和对照组患者不良反应发生率相当(7.84%比 5.88%,P>0.05).结论 活血化瘀方穴位贴敷联合阿替普酶静脉溶栓治疗脑梗死的临床疗效良好,可改善患者的中医证侯积分和氧化应激指标,促进损伤神经功能恢复,提高日常生活能力,且安全性良好.
Clinical Observation of the Acupoint Application of Huoxue Huayu Formula Combined with Intravenous Thrombolysis of Ateplase in the Treatment of Cerebral Infarction
Objective To investigate the clinical efficacy of acupoint application of Huoxue Huayu Formula combined with intravenous thrombolysis of ateplase in the treatment of cerebral infarction.Methods A total of 102 patients with cerebral infarction admitted to the hospital from January 2019 to January 2023 were selected and randomly divided into the observation group and the control group by the random number table method,with 51 cases in each group.The patients in the two groups were treated with intravenous thrombolysis of ateplase,on this basis,the patients in the observation group were treated with acupoint application of Huoxue Huayu Formula.Both groups were treated for 7 d.Results The total effective rate in the observation group was 92.16%,which was significantly higher than 72.55%in the control group(P<0.05).After treatment,the Barthel Index(BI)score in the two groups significantly increased(P<0.05),while the traditional Chinese medicine syndrome(TCM)score and the National Institutes of Health Stroke Scale(NIHSS)score significantly decreased(P<0.05),and those in the observation group were significantly better than those in the control group(P<0.05);the levels of superoxide dismutase(SOD)and glutathione peroxidase(GSH-Px)in the two groups significantly increased(P<0.05),while the levels of malondialdehyde(MDA)in the two groups significantly decreased(P<0.05),and those in the observation group were significantly better than those in the control group(P<0.05).During the treatment period,the incidence of adverse reactions in the observation group was comparable to that in the control group(7.84%vs.5.88%,P>0.05).Conclusion Acupoint application of Huoxue Huayu Formula combined with intravenous thrombolysis of ateplase has good clinical efficacy and safety in the treatment of cerebral infarction,which can improve the TCM score and oxidative stress indicators,promote the recovery of impaired neurological function,and improve the ability of daily living.

Huoxue Huayu Formulaateplasecerebral infarctionneurological functionoxidative stressclinical efficacy

杨美玉、姜尤、郭飞

展开 >

安徽中医药大学附属太和中医院,安徽 阜阳 236600

活血化瘀方 阿替普酶 脑梗死 神经功能 氧化应激 临床疗效

安徽省高等学校科研项目

2022AH050437

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(1)
  • 18